Physician profile
Katie E Green
NPI 1679853634
$1,082.44
in general payments reported to CMS, 2019-2025
20 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $190 · 2023: $472 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $320.00 | 2025 | Daxxify |
| Abbvie INC. | $125.00 | 2023 | |
| Glaxosmithkline, LLC. | $77.01 | 2023 | Trelegy Ellipta |
| Novo Nordisk INC | $75.96 | 2022-2023 | Rybelsus, Ozempic |
| Merz North America, INC. | $74.99 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.76 | 2022-2023 | |
| Corium, LLC | $44.80 | 2022-2023 | Adlarity |
| Astrazeneca Pharmaceuticals LP | $42.60 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.01 | 2023 | |
| Depuy Synthes Sales INC. | $39.97 | 2022-2023 | Orthovisc, Monovisc |
| Amgen INC. | $26.00 | 2022 | |
| Abiomed | $25.35 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.64 | 2023 | Trintellix |
| Pfizer INC. | $18.09 | 2023 | |
| Xeris Pharmaceuticals, INC. | $15.53 | 2023 | Gvoke Hypopen |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.64 | 2022 | |
| Daiichi Sankyo INC. | $14.34 | 2023 | Injectafer |
| Paratek Pharmaceuticals, INC. | $13.46 | 2023 | Nuzyra |
| Lilly USA, LLC | $13.37 | 2023 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.